Triphenylphosphonium‐conjugated poly (ε‐caprolactone)‐based self‐assembled nanostructures as nanosized drugs and drug delivery carriers for mitochondria …

DY Cho, H Cho, K Kwon, M Yu, E Lee… - Advanced Functional …, 2015 - Wiley Online Library
For mitochondria‐targeting delivery, a coupling reaction between poly (ε‐caprolactone) diol
(PCL diol) and 4‐carboxybutyltriphenylphosphonium (4‐carboxybutyl TPP) results in the …

Bioreducible poly (ethylene glycol)–triphenylphosphonium conjugate as a bioactivable mitochondria-targeting nanocarrier

Z Khatun, YS Choi, YG Kim, K Yoon… - …, 2017 - ACS Publications
Bioactivable nanocarrier systems have favorable characteristics such as high cellular
uptake, target specificity, and an efficient intracellular release mechanism. In this study, we …

Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy

W Zhou, H Yu, LJ Zhang, B Wu, CX Wang, Q Wang… - Nanoscale, 2017 - pubs.rsc.org
The importance of mitochondrial delivery of an anticancer drug to cancer cells has been
recognized to improve therapeutic efficacy. The introduction of lipophilic cations, such as …

[HTML][HTML] Charge conversion polymer–liposome complexes to overcome the limitations of cationic liposomes in mitochondrial-targeting drug delivery

PW Shueng, LY Yu, HH Hou, HC Chiu… - International Journal of …, 2022 - mdpi.com
Mitochondrial-targeting therapy is considered an important strategy for cancer treatment.(3-
Carboxypropyl) triphenyl phosphonium (CTPP) is one of the candidate molecules that can …

Charge-reversible multifunctional HPMA copolymers for mitochondrial targeting

F Wang, W Sun, L Li, L Li, Y Liu, Z Zhang… - ACS Applied Materials …, 2017 - ACS Publications
Mitochondrial-oriented delivery of anticancer drugs has been considered as a promising
strategy to improve the antitumor efficiency of chemotherapeutics. However, the …

Porphyrin Centered Paclitaxel Tetrameric Prodrug Nanoassemblies as Tumor‐Selective Theranostics for Synergized Breast Cancer Therapy

X Ma, P Wang, Q Wu, J Zhou, D Wang… - Advanced …, 2023 - Wiley Online Library
Although having undergone decades of development, nanoparticulate drug delivery
vehicles for efficient cancer therapy remain a challenge, confined by low drug loading …

Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics

S Marrache, S Dhar - … of the National Academy of Sciences, 2012 - National Acad Sciences
Mitochondrial dysfunctions cause numerous human disorders. A platform technology based
on biodegradable polymers for carrying bioactive molecules to the mitochondrial matrix …

Dual‐Targeting Polymeric Nanocarriers to Deliver ROS‐Responsive Prodrugs and Combat Multidrug Resistance of Cancer Cells

L Xi, J Wang, Y Wang, Z Ge - Macromolecular Bioscience, 2021 - Wiley Online Library
Targeting delivery of anticancer drugs that can interact with DNA into mitochondria of cancer
cells has been demonstrated to be an effective method to combat drug resistance. In this …

Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment

G Battogtokh, O Gotov, JH Kang, J Cho, TH Jeong… - …, 2018 - Future Medicine
Aim: The objective of this study was to develop a mitochondria-targeted anticancer drug,
docetaxel (DTX), for chemotherapy. Materials & methods: The DTX was conjugated to 4 …

Triphenylphosphonium-modified poly (ethylene glycol)-poly (ε-caprolactone) micelles for mitochondria-targeted gambogic acid delivery

Y Xu, S Wang, HF Chan, Y Liu, H Li, C He, Z Li… - International Journal of …, 2017 - Elsevier
Mitochondria are important targets for the intracellular delivery of drugs and DNA. For
mitochondria-targeted delivery, a mitochondriotropic molecule, triphenylphosphonium …